Articles tagged "Graft survival"

2016 American Transplant Congress
Pre-Transplant Cardiovascular Risk Factors Affect Kidney Allograft Survival: A Multi-Center Study in Korea.
J. An,^1,2 S. Ahn,³ E. Bae,² E. Kang,² H.-L. Kim,⁴ Y.-J. Kim,⁵ Y. Oh,^1,2 C. Lim,^1,2 Y. Kim,² Y. Kim,⁶ J. Lee.^1,2
¹Division of Nephrology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; ²Division of Nephrology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ³Department of Preventive Medicine, Yonsei University Wonju College of Medicine, Wonju, Gangwon-do, Korea; ⁴Division of Cardiology, Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea; ⁵Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; ⁶Department of Surgery, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Korea.
Background - Pre- or post-transplant cardiovascular (CV) risk factors affect the development of CV events even after successful kidney transplantation (KT). However, the impact of…
2016 American Transplant Congress
Long-Term Outcomes After Splenectomy for Small-for-Size Syndrome in Live Donor Liver Transplantation.
M. Dib, N. Goldaracena, A. Barbas, M. Marquez, G. Sapisochin, C. Beriault, N. Selzner, I. McGilvray, E. Renner, P. Greig, L. Lilly, A. Ghanekar, M. Cattral, M. Selzner, D. Grant.
Transplantation, Toronto General Hospital, Toronto, ON, Canada.
Introduction: The use of lower volume liver grafts has the potential to expand the donor pool in adult-to-adult live donor liver transplantation (LDLT), but is…
2016 American Transplant Congress
Outcomes for Kidney Allograft Recipients with Language Barriers Post-Transplantation – A Comparative Analysis.
S. Tahir,¹ F. Jackson-Spence,¹ H. Gillott,¹ F. Everson,² J. Nath,² A. Sharif.²
¹University of Birmingham, Birmingham, United Kingdom; ²Queen Elizabeth Hospital, Birmingham, United Kingdom.
Introduction: Patients from ethnic minorities make up an increasing number of recipients of kidney allografts in the UK. Some of these patients have language barriers…
2016 American Transplant Congress
Similar Kidney Allograft and Patient Survival in Native Americans Despite Lower Rates of Living Donation and Longer Wait on the Deceased Donor List.
H. Khamash,¹ K. Reddy,² H. Chakkera,¹ J. Huskey,¹ S. Sukumaran-Nair,¹ A. Mathur,² A. Moss,² N. Katariya,² A. Singer,² R. Heilman.¹
¹Nephrology, Mayo Clinic Arizona, Phoenix; ²Transplant Surgery, Mayo Clinic Arizona, Phoenix.
Previous studies have shown that Native Americans (NAs) have decreased access and inferior outcomes following kidney transplantation. Reviewing our center's experience we wanted to assess…
2016 American Transplant Congress
Results from 100 Consecutive Donation-After-Circulatory Death (DCD) Liver Transplants Using a Thrombolytic Protocol.
J. Seal, H. Bohorquez, N. Battula, E. Ahmed, D. Bruce, I. Carmody, R. Trevor, G. Tyson, S. Joshi, N. Bzowej, G. Therapondas, N. Girgrah, A. Cohen, G. Loss.
Multi-Organ Transplant Institute, Ochsner Clinic Foundation, New Orleans, LA.
Background: In early 2010, our center implemented a thrombolytic protocol for DCD liver transplantation in an effort to reduce biliary complications and improve graft survival.…
2016 American Transplant Congress
Relationship Between Dialisys Duration and Prevalence of Cardiovascular Diseases in Kidney Transplantation Recipients.
K. Unagami,¹ M. Okumi,² T. Hirai,² Y. Okabe,³ K. Masutani,⁴ T. Shimizu,² K. Omoto,² M. Inui,² H. Ishida,² T. Kitazono,⁴ K. Nitta,¹ K. Tanabe,² The Japan Academic Consortium of Kidney Transplantation (JACK).
¹Nephrology, Tokyo Women's Medical University, Tokyo, Japan; ²Urology, Tokyo Women's Medical University, Tokyo, Japan; ³Surgery, Kyushu University, Fukuoka, Japan; ⁴Medicine and Clinical Science, Kyushu University, Fukuoka, Japan.
Background: Among kidney transplantation (KTx) recipients, the prevalence of Cardiovascular disease (CVD) is high. However, to our knowledge, the relationship between the prevalence of CVD…
2016 American Transplant Congress
When Liver Transplants and Procurement Occur at One Location – A National Study of Graft Survivals.
J. Ortiz,¹ N. Koizumi,² C. Kwon,² Y. Zhang,² C. Ortiz.³
¹University of Toledo, Toledo, OH; ²George Mason University, Fairfax, VA; ³Bucknell University, Lewisburg, PA.
Organ procurement and placement processes entail complex scheduling, logistics and other administrative challenges, especially when organs travel outside the procuring Organ Procurement Organization (OPO) area.…
2016 American Transplant Congress
Outcomes of Pediatric en Bloc Kidney (PeB) Grafts After Loss of a Single Kidney.
C. Santhanakrishnan, R. Perez, J. McVicar, J. Sageshima, C. Troppmannn.
Division of Transplantation, Dept of Surgery, Univ of Calif Davis Medical Center, Sacramento, CA.
Background: Transplantation (Tx) of PeB kidney grafts has been shown to result in good long-term outcomes. However, the fate of PeB grafts that suffer loss…
2016 American Transplant Congress
Ischemia Reperfusion Induced Murine Heart Transplant Rejection Is Complement Dependent.
N. Chun,¹ M. Zhang,² R. Fairchild,³ P. Heeger.¹
¹Medicine, Icahn School of Medicine at Mount Sinai, NY, NY; ²Anesthesia, SUNY Downstate, NY, NY; ³Immunology, Cleveland Clinic, Cleveland, OH.
Increased posttransplant ischemia reperfusion injury (IRI) prevents costimulatory blockade induced heart graft survival but mechanisms linking innate and adaptive immunity are poorly understood. Based on…
2016 American Transplant Congress
Everolimus Plus Reduced-Exposure Cyclosporin versus Mycophenolic Acid Plus Cyclosporin: Seven-Year Follow-Up of Australia and New Zealand Kidney Transplant Recipients in the A2309 Study.
S. Chadban,¹ H. Pilmore,² G. Russ,³ J. Kanellis,⁴ S. Campbell,⁵ P. O'Connell,⁶ W. Lim,⁷ M. Lutherborrow,⁸ N. Kurstjens,⁸ R. Walker.⁹
¹Renal Medicine, Royal Prince Alfred Hospital, Sydney, Australia; ²Auckland Renal Transplant, Auckland City Hospital, Auckland, New Zealand; ³Central Northern Adelaide Ranel and Transplantation Service, Royal Adelaide Hospital, Adelaide, Australia; ⁴Renal Medicine, Monash Medical Centre, Melbourne, Australia; ⁵University of Queensland, Princess Alexandra Hospital, Queensland, Australia; ⁶Renal Medicine, Westmead Hospital, Sydney, Australia; ⁷WA Liver and Kidney Transplant Service, Sir Charles Gairdner Hospital, Perth, Australia; ⁸Novartis Pharmaceuticals, Sydney, Australia; ⁹Renal Medicine, Alfred Hospital, Melbourne, Australia.
A2309 was a 2-year, phase III randomized controlled trial evaluating the effect on graft and patient outcomes of three groups:1.5mg everolimus plus low exposure cyclosporine…